About Nextmune
Nextmune is a company based in Stockholm (Sweden) founded in 2016. It operates as a B2B and B2C. Nextmune has completed 1 acquisition, including VetBiotek. Nextmune offers products and services including Otodine, Otoact, CLX Wipes, Clorexyderm Spot Gel, and Atopi-3. Nextmune operates in a competitive market with competitors including Fitpet, Drew Scientific, Kidney-Chek, PetTest and Shop-Fitpet, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nextmune
Nextmune offers a comprehensive portfolio of products and services, including Otodine, Otoact, CLX Wipes, Clorexyderm Spot Gel, and Atopi-3.
Ear cleaning solution for dogs and cats with disinfecting properties.
Wax-dissolving cleanser for pet ears to soothe and clean.
Wet wipes for disinfecting pet skin and surfaces effectively.
Gel for treating skinfolds and moist areas in pets.
Complementary feed to support pet skin health and reduce issues.
People of Nextmune
Unlock access to complete
Funding Insights of Nextmune
Detailed funding history for Nextmune
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nextmune
Nextmune has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include VetBiotek.
Investment portfolio details for Nextmune
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Veterinary solutions are provided for managing health conditions in animals.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Nextmune
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nextmune
Detailed financials for Nextmune
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nextmune Comparisons
Peer comparison for Nextmune
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nextmune
Nextmune operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fitpet, Drew Scientific, Kidney-Chek, PetTest and Shop-Fitpet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pet disease detection is facilitated by diagnostics kits and apps.
|
|
| Locked | Locked | Locked |
Analytical Instruments for Clinical and Veterinary Hematology and HbA1c
|
|
| Locked | Locked | Locked |
At-home saliva tests for screening pet kidney diseases are provided.
|
|
| Locked | Locked | Locked |
Sells pet diabetes products like meters and syringes online.
|
|
| Locked | Locked | Locked |
Develops innovative mobile apps and kits for pet health analysis.
|
Detailed competitors of Nextmune
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nextmune
Complete news archive for Nextmune
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nextmune
Nextmune was founded in 2016.
Nextmune is headquartered in Stockholm, Sweden.
Nextmune is a science-driven specialty pharma company dedicated to improving health for dogs, cats, and horses through products in areas like allergy, dermatology, and specialized nutrition. It offers diagnostics, prescription items, and non-prescription solutions to veterinarians and pet parents worldwide. Based in the Netherlands, the company emphasizes innovation in pet healthcare, providing high-quality items via an online shop and educational resources.
Nextmune's top competitors include Fitpet, Drew Scientific and Kidney-Chek.
Nextmune offers Otodine, Otoact, CLX Wipes, Clorexyderm Spot Gel, and Atopi-3.
Nextmune has made 1 acquisition, including VetBiotek.